Home
Approach
Portfolio
News
Team
Hatchery
Contact
Home
Approach
Portfolio
News
Team
Hatchery
Contact
Rallybio to acquire Candid Therapeutics
Nia Julian
March 9, 2026
Facebook
0
Twitter
Pinterest
0
0
Likes
Previous
Biogen to buy Apellis Pharmaceuticals for $5.6 billion in rare disease push
Nia Julian
March 31, 2026
Next
Gilead to buy Arcellx in $7.8B wager on multiple myeloma cell therapy
Nia Julian
February 24, 2026
